Invitrogen™ Rabbit BLC/CXCL13 ELISA Kit

Ref.: BL-RE-091389Manufacturer ref.: ER2RB 96 tests
€760.00 excl. VAT

Rabbit BLC/CXCL13 quantitates rabbit BLC/CXCL13 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rabbit BLC/CXCL13.

Accession number
4631412M08Rik ; ANGIE ; ANGIE2 ; chimiokine à attraction des cellules B 1 ; lymphocyte B chimiotactique ; BCA1 ; BCA-1 ; cellule B chimiotactique ; chimokine à attraction des cellules B 1 ; chimiokine de domiciliation des cellules B (ligand pour le récepteur-1 de lymphomes de Burkitt) ; BLC ; BLR1L ; lymphocyte-B chimiotactique ; chimiokine à motifC C ; chimiokine à motif C x C ; chimiokine à motif CC ; chimiokine à motifCC ; chim ; ligand de chimiokine (motif C-X-C) 13 ; ligand de chimiokine (motif C-X-C) 13 (cellule B chimiotactique) ; CXC ; chimiokine CXC BLC ; chimiokine à motif CXC ; chimiokine à motif CXC 13 ; chimiokine à motif C-X-C 13 ; ligand chimiokine à motif C-X-C 13 ; CXCL ; CXCL13 ; SCYB13 ; sous-famille de cytokine B inductible de petite taille (motif Cys-X-Cys), membre 13 (cellule B chimiotactique) ; sous-famille de cytokine B inductible de petite taille (Cys-X-Cys), membre 13 ; cytokine B13 inductible de petite tail
Dose range
0.35 to 80 ng/ml
Sensitivity of the dosage
0.35 ng/ml
Conjugate
Biotin
Product type
ELISA
Brand
Invitrogen

Rabbit BLC/CXCL13 quantitates rabbit BLC/CXCL13 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rabbit BLC/CXCL13.

Rabbit BLC/CXCL13 quantitates rabbit BLC/CXCL13 in serum, plasma, supernatant. The assay will exclusively recognize both natural and recombinant rabbit BLC/CXCL13.

CXCL13, also known as BCA-1 and Angie, is a small chemokine strongly expressed in secondary lymphoid organs. It preferentially promotes the migration of B lymphocytes (B-1 and B-2) to spleen follicles, lymph nodes, and Peyer plaques. It is produced by macrophages and, in mice, the largest constituent producers include large peritoneal macrophages, Kuppfer cells, and lung macrophages (CD11c+ and CD11c-). The cell ligand for CXCL13 is CXCR5 also known as BLR-1 (Burkitt lymphoma receptor 1). CXCR5 is expressed on B cells, Tfh cells and, to a lesser extent, certain populations of memory T cells. CXCL13 plays an important role in the development of chronic lymphoid leukemia (LLC). CXCL13 is also a plasma biomarker for germ centre activity and the generation of largely neutralizing antibodies against VIH.

Sensitivity

Sensitivity of the dosage: 0.35 ng/ml.

Measurement range

Dose range: 0.35 to 80 ng/ml.

Duration of dosing

Total duration of dosing: 4 h 45 min.

Target

Target: CXCL13.

Samples

Sample type: Plasma, Serum, Surnatant (plasma volume, 50 µl; supernatant, 50 µl; serum, 50 µl).

Technical specifications

General
BrandInvitrogen
Supplier ref. (Fisher Scientific)17155013
Specifications
Accession number4631412M08Rik; ANGIE; ANGIE2; chemokin at attraction of B 1 cells; lymphocyte B chemotactic; BCA1; BCA-1; chemotactic B cell; chemokine at attraction of B 1 cells; chemokine of homeiation of B cells (ligand for Burkitt lymphoma receptor-1); BLC; BLR1L
Dose range0.35 to 80 ng/ml
Sensitivity of the dosage0.35 ng/ml
ConjugateBiotin
Product typeELISA
Type of samplePlasma, Serum, Surnatant
For use with (equipment)Colorimetric microplate reader
Gene symbol(s)Cxcl13
Coefficient of inter-dose variation<12%
Coefficient of intra-dose variation<10%
Contents of kits96 pre-coated well plate, standard, dosing diluent concentrate, biotinylated detection antibody, SAV-HRP, washing pad, chromogen, stop solution, adhesive plate lids
Marker or dyeHRP
Quantity96 tests
Regulatory statusUse exclusively for research
TargetCXCL13
Test time1 h 20 min
Physical characteristics
Volume of samplePlasma, 50 µl; supernatant, 50 µl; serum, 50 µl
Storage and shipping
Storage conditions2°C to 8°C
Total duration of dosing4 h 45 min

Origin and customs

Manufacturer ref.ER2RB
Country of originUnited States
HS customs code3002 12 00 00
A question or a specific configuration?
Contact us for a quote.